Published in BMC Cardiovasc Disord on August 30, 2006
Electronic medication packaging devices and medication adherence: a systematic review. JAMA (2014) 1.12
Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review. J Gen Intern Med (2010) 1.03
The potential impact of intelligent systems for mobile health self-management support: Monte Carlo simulations of text message support for medication adherence. Ann Behav Med (2015) 0.80
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility. Vasc Health Risk Manag (2009) 0.76
Persistence with treatment for hypertension in actual practice. CMAJ (1999) 2.74
Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ (1999) 2.44
Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens (2001) 1.80
Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs (1995) 1.75
Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension (1998) 1.32
Validation of A&D UA-767 device for the self-measurement of blood pressure. Blood Press Monit (2000) 1.28
Comparing compliance patterns between randomized treatments. Control Clin Trials (1997) 1.25
Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther (1994) 1.16
Noncompliance may cause half of antihypertensive drug "failures". JAMA (1999) 1.15
Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens (1996) 1.06
Evaluation of Meditech ABPM-04 ambulatory blood pressure measuring device according to the British Hypertension Society protocol. Blood Press Monit (1998) 1.02
User procedure for self-measurement of blood pressure. First International Consensus Conference on Self Blood Pressure Measurement. Blood Press Monit (2000) 1.01
Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life. Br J Clin Pharmacol (1996) 0.92
A Study Design for Comparing the Effects of Missing Daily Doses of Antihypertensive Drugs. Am J Ther (1994) 0.89
Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients. J Cardiovasc Pharmacol (1995) 0.81
The effects of missing a dose of enalapril versus amlodipine on ambulatory blood pressure. Blood Press Monit (1996) 0.81
Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. J Clin Pharmacol (2005) 1.50
Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S. mansoni egg antigens. J Clin Microbiol (2002) 1.39
Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int (2004) 1.39
A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens (2008) 1.30
Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. Blood (2004) 1.27
Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulm Pharmacol Ther (2004) 1.18
Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A (2008) 1.14
Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif (2003) 1.04
Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells. Biochem Biophys Res Commun (2002) 1.03
Innovative ICT solutions to improve treatment outcomes for depression: the ICT4Depression project. Stud Health Technol Inform (2012) 1.00
Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. J Pharmacokinet Pharmacodyn (2007) 0.98
Novel NCCT gene mutations as a cause of Gitelman's syndrome and a systematic review of mutant and polymorphic NCCT alleles. Kidney Blood Press Res (2002) 0.94
Epidermal growth factor stimulates Rac1 and p21-activated kinase in vascular smooth muscle cells. Atherosclerosis (2007) 0.92
Destabilization of AT(1) receptor mRNA by calreticulin. Circ Res (2002) 0.92
Telemonitoring of blood pressure self measurement in the OLMETEL study. Blood Press Monit (2004) 0.90
Development of a dipstick assay for detection of Leishmania-specific canine antibodies. J Clin Microbiol (2004) 0.89
Multiple benign symmetric lipomatosis--a differential diagnosis of obesity: is there a rationale for fibrate treatment? Obes Surg (2008) 0.89
Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens (2009) 0.88
Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins. In Vitro Cell Dev Biol Anim (2002) 0.87
Identification of Nck interacting proteins in vascular smooth muscle cells. Clin Exp Hypertens (2004) 0.86
Relationship between the frequency of blood pressure self-measurement and blood pressure reduction with antihypertensive therapy : results of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study. Clin Drug Investig (2006) 0.85
ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring. J Hypertens (2003) 0.85
Identification of p54(nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells. J Biochem Mol Biol (2005) 0.84
The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis. J Mol Med (Berl) (2002) 0.84
Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation. Eur J Nutr (2002) 0.84
Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins. Eur J Nutr (2007) 0.83
Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism. Pulm Pharmacol Ther (2008) 0.83
Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicol Lett (2004) 0.83
Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway. Eur J Nutr (2007) 0.82
Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study. J Toxicol Environ Health A (2008) 0.81
17 Beta-estradiol regulates the expression of endothelin receptor type B in the heart. Br J Pharmacol (2003) 0.81
Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. Eur J Pharmacol (2004) 0.81
Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch Toxicol (2002) 0.80
Polymorphic metabolic susceptibility genes and longevity: a study in octogonarians. Toxicol Lett (2004) 0.80
Myocardial ischemia during everyday life in patients with arterial hypertension: prevalence, risk factors, triggering mechanism and circadian variability. Blood Press Monit (2006) 0.80
Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. Anticancer Drugs (2005) 0.80
Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling. Phytomedicine (2008) 0.80
Multiple benign symmetric lipomatosis--a differential diagnosis of obesity. Is there a rationale for fibrate treatment? Obes Surg (2008) 0.79
Evaluation of the performance of a wrist blood pressure measuring device with a position sensor compared to ambulatory 24-hour blood pressure measurements. Am J Hypertens (2002) 0.79
Short-term effects of exogenous angiotensin II on plasma fibrinolytic balance in normal subjects. Clin Exp Hypertens (2004) 0.78
Differential effects of fexofenadine on arachidonic acid metabolism in cultured human monocytes. Pharmacology (2005) 0.77
New evidence of H1-receptor independent COX-2 inhibition by fexofenadine HCl in vitro. Pharmacology (2006) 0.77
Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimen. Clin Trials (2009) 0.77
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study. Biomed Res Int (2013) 0.77
Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers. Mol Nutr Food Res (2010) 0.77
Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells. Rheumatol Int (2008) 0.77
Significance of blood pressure self-measurement as compared with office blood pressure measurement and ambulatory 24-hour blood pressure measurement in pharmacological studies. Blood Press Monit (2003) 0.76
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility. Vasc Health Risk Manag (2009) 0.76
Macrophage-like synoviocytes display phenotypic polymorphisms in a serum-free tissue-culture medium. Rheumatol Int (2004) 0.76
Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach. Arch Toxicol (2006) 0.75
Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis. Artif Organs (2006) 0.75
Morning blood pressure surge and the risk of stroke. Circulation (2003) 0.75
Cost-effectiveness of a nurse-based intervention (AIMS) to improve adherence among HIV-infected patients: design of a multi-centre randomised controlled trial. BMC Health Serv Res (2013) 0.75
A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer. Int J Mol Med (2005) 0.75
The use of suppression subtractive hybridization for the study of SDF-1alpha induced gene-expression in human endothelial cells. Mol Cell Probes (2003) 0.75
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma. J Neurol (2002) 0.75
Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 (4N1-1) is inhibited by epigallocatechin gallate but not by prostaglandin E1. Platelets (2004) 0.75
Risk of hepatitis C after immunoadsorption. Infect Control Hosp Epidemiol (2002) 0.75
Differential effect of acute angiotensin II type 1 receptor blockade on the vascular and adrenal response to exogenous angiotensin II in humans. Am J Hypertens (2003) 0.75
Simultaneous recording of blood pressure and ST-segment with combined, triggered ambulatory 24-h devices. Blood Press Monit (2003) 0.75
Pulse wave velocity is increased in patients with transient myocardial ischemia. J Hypertens (2006) 0.75